Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: Rationale and design of the MICROCARD study

Nephrology Dialysis Transplantation

Volumn 27, Issue 7, 2012, Pages 2886-2891

  Bejan Angoulvant, Theodora ^a,b   Bergerot, Cyrille ^c   Juillard, Laurent ^b,d   Mezergues, Aline ^e,f   Morelon, Emmanuel ^b,g   Pouteil Noble, Claire ^b,h   André Fouët, Xavier ^b,i   Angoulvant, Denis ^b,i  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Hospices Civils de Lyon   (France)

^d Nephrologie Hypertension Hemodialyse Nutrition   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f Groupement Hospitalier Est   (France)

^g Transplantation et Immunologie Clinique   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ Groupement Hospitalier Est   (France)

Author keywords

coronary flow reserve; end stage renal disease; major adverse cardiovascular events; myocardial microvascular disease; observational prospective cohort study

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISSECTION; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MICROCARD STUDY; MYOCARDIAL MICROVASCULAR DISEASE; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; STROKE; TYPES OF STUDY;

AGED; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84864415126     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs008     Document Type: Article

References (29)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (5 Suppl 3): S112-S119.
2. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
3. Hage F, Smalheiser S, Zoghbi G et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol 2007; 100: 1020-1025.
4. Bergeron S, Hillis GS, Haugen EN et al. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 2007; 153: 385-391.
5. De Lima JJ, Sabbaga E, Vieira ML et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42: 263-268.
6. De Lima JJ, Wolff Gowdak LH, de Paula FJ et al. Validation of a strategy to diagnose coronary artery disease and predict cardiac events in high-risk renal transplant candidates. Coron Artery Dis 2010; 21: 164-167.
7. Venkataraman R, Hage FG, Dorfman T et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol 2008; 102: 1451-1456.
8. Ronco C, Haapio M, House AA et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
9. USRDS. 2010 Annual Data Report Bethesda, MD: National Institutes of Health, 2010. http://www.usrds.org/reference.htm. Last accessed on 04/21/2011.
10. Couchoud C, Lassalle M, Stengel B et al. Renal Epidemiology and Information Network: 2007 annual report. Nephrol Ther 2009; 5 (Suppl 1): S3-S144.
11. Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407.
12. Wanner C, Krane V, Marz Wet al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
13. Zannad F, Kessler M, Lehert P et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006; 70: 1318-1324.
14. Strippoli GF, Navaneethan SD, Johnson DW et al. Effects of statins in patients with chronic kidney disease: meta-analysis and metaregression of randomised controlled trials. BMJ 2008; 336: 645-651.
15. Karumanchi SA, Thadhani R. Kidney complications: why don't statins always work? Nat Med 2010; 16: 38-40.
16. Pries AR, Habazettl H, Ambrosio G et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008; 80: 165-174.
17. Fearon WF, Balsam LB, Farouque HM et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003; 107: 3129-3132.
18. Fearon WF, Aarnoudse W, Pijls NH et al. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation 2004; 109: 2269-2272.
19. Pijls NH, De Bruyne B, Smith L et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 2002; 105: 2482-2486.
20. McCullough PA. Coronary artery disease. Clin J Am Soc Nephrol 2007; 2: 611-616.
21. Pijls NH, De Bruyne B, Peels K et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708.
22. Kern MJ, Lerman A, Bech JW et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 2006; 114: 1321-1341.
23. Tonino PA, De Bruyne B, Pijls NH et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-224.
24. Casella G, Leibig M, Schiele TM et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 2004; 148: 590-595.
25. De Luca G, Venegoni L, Iorio S et al. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. J Am Coll Cardiol Intv 2011; 4: 1079-1084.
26. Karthikeyan V, Ananthasubramaniam K. Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation. Curr Cardiol Rev 2009; 5: 177-186.
27. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
28. Rakhit DJ, Armstrong KA, Beller E et al. Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. Am Heart J 2006; 152: 363-370.
29. Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 2207-2214.